Clinical Trial Update: Cefotetan Therapy for Escherichia Coli Infections [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating cefotetan for Escherichia coli infections, including ESBL-producing strains, which is currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esbl-producing Escherichia Coli Infection
• Escherichia Coli Infection

Drugs mentioned

• Cefotetan (cefotetan)

Snippet

Sponsor: Oregon Health and Science University | Conditions: E Coli Infection, ESBL Producing E.Coli | Phase 2 | Status: NOT_YET_RECRUITING